Literature DB >> 28455215

Effect of the lipoxygenase-inhibitors baicalein and zileuton on the vertebra in ovariectomized rats.

D Saul1, S Gleitz2, H H Nguyen2, R L Kosinsky3, S Sehmisch2, D B Hoffmann2, M Wassmann4, B Menger2, M Komrakova2.   

Abstract

Osteoporosis is one of the most common diseases worldwide. In osteoporosis, vertebral fractures represent a major burden. Lipoxygenase (LOX) inhibitors such as baicalein and zileuton may represent a promising therapeutic option owing to their antioxidative effects and suppression of various inflammatory processes in muscle and bone. The effect of these LOX inhibitors on the spine was studied in osteopenic rats. Female Sprague-Dawley rats were divided two times into five groups: four groups each were ovariectomized (OVX) and one control group was non-ovariectomized (NON-OVX). Eight weeks after ovariectomy, three concentrations of baicalein (1mg/kg body weight [BW], 10mg/kgBW, and 100mg/kgBW) were administered subcutaneously daily in three OVX groups for 4weeks. Similarly, zileuton was administered in three concentrations via food for 5weeks. In vivo computed tomography (pQCT) of the spine was performed before the treatments and at the end of the experiment. Lumbar vertebrae were subjected to a compression test, micro-CT, and ashing analyses. After baicalein treatment, cortical bone mineral density (BMD) was improved; trabecular connectivity and trabecular BMD were diminished at high dose. After zileuton treatment, the total BMD, anorganic weight, trabecular nodes, and trabecular area were improved. The in vivo stress-strain index was increased and alkaline phosphatase activity in serum was enhanced after both treatments. A dose-dependent effect was not clearly observed after both treatments. The treatments using baicalein for 4 and zileuton for 5weeks were not sufficient to change the biomechanical properties and bone volume fraction (BV/TV). Overall, baicalein improved the cortical bone parameters whereas zileuton had a favorable effect on the trabecular structure. Moreover, both treatments increased the bone formation rate. Longer trials, a combination of both LOX inhibitors, and their effect at the cellular and molecular levels should be investigated in further studies.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Baicalein; Lipoxygenase-inhibitors; Osteoporosis; Spine; Zileuton

Mesh:

Substances:

Year:  2017        PMID: 28455215     DOI: 10.1016/j.bone.2017.04.011

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  6 in total

1.  Effect of the lipoxygenase inhibitor baicalein on bone tissue and bone healing in ovariectomized rats.

Authors:  Marina Komrakova; Stephan Sehmisch; Dominik Saul; Marie Weber; Marc Hendrik Zimmermann; Robyn Laura Kosinsky; Daniel Bernd Hoffmann; Björn Menger; Stefan Taudien; Wolfgang Lehmann
Journal:  Nutr Metab (Lond)       Date:  2019-01-11       Impact factor: 4.169

Review 2.  Iron Complexes of Flavonoids-Antioxidant Capacity and Beyond.

Authors:  Zdeněk Kejík; Robert Kaplánek; Michal Masařík; Petr Babula; Adam Matkowski; Petr Filipenský; Kateřina Veselá; Jakub Gburek; David Sýkora; Pavel Martásek; Milan Jakubek
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

3.  Combination of selective androgen and estrogen receptor modulators in orchiectomized rats.

Authors:  S Sehmisch; M Komrakova; P J Roch; V Wolgast; M-M Gebhardt; K O Böker; D B Hoffmann; D Saul; A F Schilling
Journal:  J Endocrinol Invest       Date:  2022-04-16       Impact factor: 5.467

4.  Baicalein Nanofiber Scaffold Containing Hyaluronic Acid and Polyvinyl Alcohol: Preparation and Evaluation

Authors:  Kamel Bachimam; Ezgi Emül; Necdet Sağlam; Feza Korkusuz
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

5.  An In Silico Study of the Antioxidant Ability for Two Caffeine Analogs Using Molecular Docking and Quantum Chemical Methods.

Authors:  Josivan da Silva Costa; Ryan da Silva Ramos; Karina da Silva Lopes Costa; Davi do Socorro Barros Brasil; Carlos Henrique Tomich de Paula da Silva; Elenilze Figueiredo Batista Ferreira; Rosivaldo Dos Santos Borges; Joaquín María Campos; Williams Jorge da Cruz Macêdo; Cleydson Breno Rodrigues Dos Santos
Journal:  Molecules       Date:  2018-10-29       Impact factor: 4.411

6.  Inhibition of Lipoxygenases Showed No Benefit for the Musculoskeletal System in Estrogen Deficient Rats.

Authors:  Dominik Saul; Friederike Eva Hohl; Max Konrad Franz; Ilka Meyer; Stefan Taudien; Paul Jonathan Roch; Stephan Sehmisch; Marina Komrakova
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-20       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.